Zai Lab
Zai Lab, a Shanghai-based biopharmaceutical company, develops and manufactures treatments for oncology, autoimmune, and infectious diseases globally.
Founded
2014Zai Lab, a Shanghai-based biopharmaceutical company, develops and manufactures treatments for oncology, autoimmune, and infectious diseases globally.
Founded in Shanghai, China, Zai Lab is a biopharmaceutical company committed to developing and manufacturing innovative treatments for oncology, autoimmune, and infectious diseases. With a global market focus, Zai Lab offers a range of therapeutic products including capsules, injections, and liquids. The company's core mission is to bring transformative medicines to patients worldwide, leveraging cutting-edge research and development to address critical healthcare needs.
Zai Lab's notable affiliations include partnerships with leading global pharmaceutical companies and a robust network of investors supporting its mission. Over the past decade, Zai Lab has achieved significant milestones, including the successful commercialization of multiple therapies and expansion into the U.S. market. The company's impact is evident in its contributions to global health, providing advanced treatment options and improving patient outcomes across various medical conditions.
Companies similar to Zai Lab include Shanghai Junshi Biosciences Co, Innovent Biologics, Livzon Mabpharm and BioRay Pharmaceuticals.
Zai Lab was founded in 2014.
Zai Lab's headquarters is located in Shanghai, CN.
Zai Lab's most recent funding round was for $857.5M (USD) in April 2021.
As of Apr 19, 2021, Zai Lab has disclosed funding of $1.7B (USD). Undisclosed round amounts are excluded.
Zai Lab has 2,036 employees as of Feb 6, 2024.
BioRay Pharmaceuticals
